Showing 2,392 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

HIV treatment

2023 HIV Market Report: The state of HIV market in low- and middle-income countries

Editor's pick
Clinton Health Access Initiative
31 October 2023
Weight gain & lipodystrophy

GLP-1 receptor agonists promote weight loss among people with HIV One Quarter of PWH Lose More Than 5% of Weight With GLP-1 Agonists

Editor's pick
NATAP
27 October 2023
Hepatitis B

HBcAb positivity is a risk factor for failure to achieve complete virologic suppression of HIV-RNA after antiretroviral switch to 3TC+DTG

Editor's pick
NATAP
27 October 2023
Changing treatment

One Third of French Group Has Not Changed Antiretrovirals for Over 10 Years

Editor's pick
NATAP
27 October 2023
Injectable & long-acting HIV treatment

Cabotegravir/Rilpivirine Injections Administered During Home Health Visit Show Promise in Pilot Study

Editor's pick
TheBodyPro
26 October 2023
Injectable & long-acting HIV treatment

ViiV Healthcare receives approval from China’s national medical products administration for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine)

Editor's pick
ViiV press release
26 October 2023
People & personal stories

From HIV to obesity – Professor Francois Venter on fighting for better health for more people

Editor's pick
Daily Maverick
25 October 2023
Mental & emotional health & wellbeing

PrEP Adherence and Depression Screening in LGBTQ+ Communities

Editor's pick
Infectious Disease Advisor
24 October 2023
Economic & social inequality

10 Charged in $20 Million Scheme to Sell Black-Market HIV Drugs

Editor's pick
The New York Times
23 October 2023
Weight gain & lipodystrophy

Weight Loss or Gain Predictors Hard to Find in INSTI-to-PI Switch Trial

Editor's pick
NATAP
19 October 2023
Bad science & bogus treatments

Beware of this dangerous advice! Colloidal silver cannot be used as an antibiotic or HIV medication

Editor's pick
Africa Check
19 October 2023
People with limited treatment options

Sunlenca Remains Active Against Drug-Resistant HIV

Editor's pick
POZ
19 October 2023
HIV treatment

Real-World Evidence Reinforces Biktarvy® as a Long-Term Treatment Option With a High Barrier to Resistance for People With HIV and a Range of Comorbidities

Editor's pick
Gilead Sciences press release
19 October 2023
People with limited treatment options

Intramuscular Administration of HIV Treatment Ibalizumab Compared With IV Infusion

Editor's pick
Monthly Prescribing Reference
17 October 2023
Hepatitis B

Hepatitis B Reactivation Risk Low in People With HIV Following Antiretroviral Switch

Editor's pick
Contagion Live
17 October 2023
Injectable & long-acting HIV treatment

Over 80% With Detectable HIV Load Respond to CAB + RPV LA

Editor's pick
NATAP
17 October 2023
Injectable & long-acting HIV treatment

Treatment Adherence, Persistence in HIV Improves After Switch to Long-Acting ART

Editor's pick
Infectious Disease Advisor
17 October 2023
People with limited treatment options

Long-Term Outcomes of Fostemsavir in HTE Adults With Advanced HIV

Editor's pick
Infectious Disease Advisor
17 October 2023
Starting treatment

Data Support ART Initiation During Earliest Stage of Acute HIV Infection

Editor's pick
Infectious Disease Advisor
9 October 2023
Pharmaceutical industry

People with HIV offered hope of self-injected drug at home

Editor's pick
The Guardian
3 October 2023
Injectable & long-acting HIV treatment

Could this new hydrogel make HIV therapy more convenient?

Editor's pick
EurekAlert!
28 September 2023
Bad science & bogus treatments

Iceland boss retracts HIV needle staff attack claim

Editor's pick
BBC News
26 September 2023
Improving HIV care

Clinicians Weigh In on the Benefits of Rapid Antiretroviral Therapy for HIV in Emergency Departments

Editor's pick
Infectious Disease Advisor
25 September 2023
Treatment guidelines

Long-Acting Cabotegravir-Rilpivirine for People Not Taking Oral Therapy — Time to Modify Treatment Guidelines?

Editor's pick
HIV and ID Observations
25 September 2023
This block is broken or missing. You may be missing content or you might need to enable the original module.